Aegea Biotechnologies’ New, Highly Sensitive PCR-based COVID-19 Assay Utilizing Patented Switch-Blocker Technology Advances in the Global XPRIZE Competition Seeking “Faster, Cheaper, and Easier-to-Use COVID-19 Testing Methods at Scale” [14-September-2020] SAN DIEGO , Sept. 14, 2020 /PRNewswire/ -- Aegea Biotechnologies, Inc. ( www.aegeabiotech.com , “Aegea”)
September 14, 2020
· 4 min read